Unsettled issues with oral antiplatelet therapy: which one? How much? How long?
Presentations available when logged in:
- Prevalence and predictors of dual antiplatelet therapy non-compliance after DES placement: 1-year results from the XIENCE V USA study
- Effect of shorter dual antiplatelet therapy on 1-year clinical outcomes after implantation of DES
- Comparison of clinical efficacy and safety of clopidogrel resinate with clopidogrel bisulfate in patients undergoing PCI
- Prasugrel versus clopidogrel in medically managed unstable angina/NSTEMI: insights from the TRILOGY ACS platelet substudy in angiographically triag...
- Clinical outcomes associated with dual antiplatelet therapy interruption following implantation of the Resolute zotarolimus-eluting stent
- Clinical outcomes with 6-month dual antiplatelet therapy after implantation of Biolimus-A9 drug-eluting coronary stents
- Switching from clopidogrel to prasugrel in patients having coronary stent implantation
- Comparison of clopidogrel and prasugrel in patients with unprotected left main disease treated with everolimus-eluting stents: insight from the Flo...